Table 2.
Follow-up strategy based on risk groups (adapted from [4]).
| Initial estimate of risk of recurrence first 2 years of followup incomplete response | |||
|---|---|---|---|
| Suppressed Tg | Low risk Q 6 months |
Intermediate risk Q 6 months |
High risk Q 6 months |
| Stimulated Tg | Not required | <10 ng/mL | >10 ng/mL |
| Neck ultrasound | Q year × 2 | Q year × 2 | Q year × 2 |
| Diagnostic RAI WBS | Not required | 1-2 years | 1-2 years |
| Cross-sectional imaging (MRI, CT) | Not required | Not required | If Tg elevated or high clinical suspicion |
|
| |||
| Secondary risk stratification response to therapy assessment | |||
|
| |||
| Ongoing followup | Yearly physical examination, yearly suppressed Tg | Yearly physical examination, yearly suppressed Tg, stimulated Tg to document undetectable Tg on suppression, continued observation/assessment of indeterminate structural abnormalities for at least another 2-3 years |
Consider additional cross-sectional imaging, possibly FDG PET scan and the need for additional therapy |